These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28050036)

  • 1. Irritable Bowel Syndrome-Like Symptoms Following Fecal Microbiota Transplantation: A Possible Donor-Dependent Complication.
    Chang BW; Rezaie A
    Am J Gastroenterol; 2017 Jan; 112(1):186-187. PubMed ID: 28050036
    [No Abstract]   [Full Text] [Related]  

  • 2. [Faecal microbiota transplantation for the treatment of bowel disease].
    Rode AA; Chehri M; Petersen AM; Bytzer P
    Ugeskr Laeger; 2017 Jul; 179(31):. PubMed ID: 28869008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal Microbiota Transplantation.
    Vindigni SM; Surawicz CM
    Gastroenterol Clin North Am; 2017 Mar; 46(1):171-185. PubMed ID: 28164849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fecal microbiota transplantation: past, present and future perspectives.
    Bibbò S; Ianiro G; Gasbarrini A; Cammarota G
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):420-430. PubMed ID: 28927251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-Discordant Fecal Microbiota Transplantation for Clostridioides difficile May Increase Risk of Postinfection Irritable Bowel Syndrome.
    Sehgal K; Yadav D; Saha S; Mara K; Grover M; Khanna S
    Gastroenterology; 2024 Apr; 166(4):704-706.e2. PubMed ID: 38056511
    [No Abstract]   [Full Text] [Related]  

  • 6. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
    Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
    Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
    Woodworth MH; Neish EM; Miller NS; Dhere T; Burd EM; Carpentieri C; Sitchenko KL; Kraft CS
    J Clin Microbiol; 2017 Apr; 55(4):1002-1010. PubMed ID: 28077694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal microbiota transplantation for gastrointestinal disorders.
    Malikowski T; Khanna S; Pardi DS
    Curr Opin Gastroenterol; 2017 Jan; 33(1):8-13. PubMed ID: 28134687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal microbiota transplantation for managing irritable bowel syndrome.
    El-Salhy M; Mazzawi T
    Expert Rev Gastroenterol Hepatol; 2018 May; 12(5):439-445. PubMed ID: 29493330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fecal Microbiota Transplantations: Where Are We, Where Are We Going, and What Is the Role of the Clinical Laboratory?
    Ransom EM; Burnham CD; Jones L; Kraft CS; McDonald LC; Reinink AR; Young VB
    Clin Chem; 2020 Apr; 66(4):512-517. PubMed ID: 32232453
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fecal transplantation the future therapy?].
    Rebizak E; Sierant K; Łabuzek K; Okopień B
    Pol Merkur Lekarski; 2015 Aug; 39(230):73-6. PubMed ID: 26319378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor Considerations in Fecal Microbiota Transplantation.
    Barnes D; Park KT
    Curr Gastroenterol Rep; 2017 Mar; 19(3):10. PubMed ID: 28289858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can you cause inflammatory bowel disease with fecal transplantation? A 31-patient case-series of fecal transplantation using stool from a donor who later developed Crohn's disease.
    Fischer M; Bittar M; Papa E; Kassam Z; Smith M
    Gut Microbes; 2017 May; 8(3):205-207. PubMed ID: 28103145
    [No Abstract]   [Full Text] [Related]  

  • 14. Challenges in fecal donor selection and screening for fecal microbiota transplantation: A review.
    Woodworth MH; Carpentieri C; Sitchenko KL; Kraft CS
    Gut Microbes; 2017 May; 8(3):225-237. PubMed ID: 28129018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Durable coexistence of donor and recipient strains after fecal microbiota transplantation.
    Li SS; Zhu A; Benes V; Costea PI; Hercog R; Hildebrand F; Huerta-Cepas J; Nieuwdorp M; Salojärvi J; Voigt AY; Zeller G; Sunagawa S; de Vos WM; Bork P
    Science; 2016 Apr; 352(6285):586-9. PubMed ID: 27126044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic modulation of intestinal microbiota in irritable bowel syndrome. From probiotics to fecal microbiota therapy].
    Konturek PC; Zopf Y
    MMW Fortschr Med; 2017 Dec; 159(Suppl 7):1-5. PubMed ID: 29204952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota Replacement Therapies: Innovation in Gastrointestinal Care.
    Khanna S
    Clin Pharmacol Ther; 2018 Jan; 103(1):102-111. PubMed ID: 29071710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress with treating the microbial dysbiosis associated with irritable bowel syndrome.
    Pearson JS; Whorwell PJ
    Curr Opin Gastroenterol; 2017 Jan; 33(1):21-25. PubMed ID: 28134688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of an anaerobic cultured human intestinal microbiota, ACHIM, for treatment of IBS.
    Benno P; Norin E; Midtvedt T; Hellström PM
    Best Pract Res Clin Gastroenterol; 2019; 40-41():101607. PubMed ID: 31594647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.